TTAM Research Institute to Carry Forward 23andMe’s Mission
This message is for current customers of 23andMe – if you are a former customer or a customer who has deleted your information, please disregard this notice.
On June 27, 2025, the U.S. Bankruptcy Court for the Eastern District of Missouri approved the proposed purchase of all of the assets of 23andMe by TTAM Research Institute (“TTAM”), and we anticipate that the sale will close on or as soon as reasonably practicable after July 8, 2025.
TTAM is a nonprofit medical research organization founded by Anne Wojcicki (Co-Founder and former CEO of 23andMe). TTAM’s charitable mission is to continue the innovative research and scientific discoveries that were core to 23andMe, while expanding its active conduct of medical research and educational activities to empower individuals to learn about their own genomes and advance our knowledge of human health.
Customer privacy is at the core of TTAM’s mission of helping individuals gain insight into, and benefit from, their genetic information. TTAM is committed to adhering to 23andMe’s existing privacy policies of always honoring customers with choice and transparency. To see your individual privacy settings you can click here.
We have seen how important genetic information is to all of our lives and we are committed to continuing to serve our customers, deliver meaningful genetic insights to them and the broader community and expand medical research that unlocks the power of human genetics.
We plan to continue providing the same types of products and services 23andMe has provided and we also look forward to expanding the innovative research and scientific discoveries that were core to 23andMe, now as a nonprofit research institution with a mission of collecting and analyzing genetic data on an unprecedented scale in pursuit of education, medical research and scientific discovery for the benefit of all.
What this means for you:
No action is required by you. Your account and personal data remain intact and will continue to be safeguarded under 23andMe’s privacy commitments to you.
Your personal information has not been physically or electronically moved from the control of 23andMe.
TTAM is legally obligated to maintain and honor the privacy policies, user consents, and data protection measures that have been put in place by 23andMe.
TTAM will be operating with the same employees and privacy protocols that have protected your data and is committed to continuous improvement of those policies.
You will continue to be able to exercise your choices on how your data and collected samples are used, including opting into or out of research and deleting your account by going to Account Settings and clicking the “Permanently Delete Data” button. If you have any issues, you can contact customercare@23andme.com for further assistance. If you have previously chosen to delete your data, no further action is necessary.
Looking Ahead
We are incredibly excited to build on 23andMe’s legacy. 23andMe pioneered the ability for individuals to learn valuable genetic insights and to contribute to advancing our knowledge of human genetics. TTAM, as a non-profit dedicated to education and the active conduct of medical research, will be best positioned to accelerate our understanding of genetics, empower individuals through knowledge and advance research that benefits all.
23andMe Holding Co. Bankruptcy Noticing
Kroll Restructuring Administration LLC, 1 World Trade Center, 31st Floor, New York, NY 10007